• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Venous thromboembolism prophylaxis-prescribing patterns among elderly medical patients in a Saudi tertiary care center: success or failure?沙特一家三级医疗中心老年内科患者的静脉血栓栓塞预防用药模式:成功还是失败?
J Geriatr Cardiol. 2020 Dec 28;17(12):775-781. doi: 10.11909/j.issn.1671-5411.2020.12.004.
2
Safety and effectiveness of thromboprophylaxis use in hospitalized elderly medical patients at a Saudi tertiary care center.沙特一家三级医疗中心住院老年内科患者使用血栓预防措施的安全性和有效性。
Saudi Pharm J. 2021 May;29(5):456-461. doi: 10.1016/j.jsps.2021.04.008. Epub 2021 Apr 28.
3
Thromboprophylaxis rates in US medical centers: success or failure?美国医疗中心的血栓预防率:成功还是失败?
J Thromb Haemost. 2007 Aug;5(8):1610-6. doi: 10.1111/j.1538-7836.2007.02650.x.
4
Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.对有静脉血栓栓塞风险的住院内科和外科患者实施血栓预防的干预措施。
Cochrane Database Syst Rev. 2013 Jul 16(7):CD008201. doi: 10.1002/14651858.CD008201.pub2.
5
Real-life use of thromboprophylaxis in patients hospitalized for pulmonary disorders: A single-center retrospective study.肺部疾病住院患者血栓预防的实际应用:一项单中心回顾性研究。
Adv Clin Exp Med. 2018 Feb;27(2):237-243. doi: 10.17219/acem/68474.
6
An assessment of surgical thromboprophylaxis in a tertiary care center.三级护理中心的外科血栓预防评估。
Clin Appl Thromb Hemost. 2011 Nov-Dec;17(6):E39-45. doi: 10.1177/1076029610382652. Epub 2010 Sep 9.
7
Venous thromboembolism in hospitalized patients: an updated analysis of missed opportunities for thromboprophylaxis at a university-affiliated tertiary care center.住院患者的静脉血栓栓塞:对一所大学附属医院三级医疗中心预防血栓形成错失机会的最新分析。
Vasc Med. 2014 Oct;19(5):385-91. doi: 10.1177/1358863X14543737. Epub 2014 Jul 29.
8
Incidence of thromboembolism and thromboprophylaxis in medical patients admitted to specialized hospital in Ethiopia using Padua prediction score.在埃塞俄比亚一家专科医院收治的内科患者中,使用帕多瓦预测评分评估静脉血栓栓塞症的发病率及血栓预防情况
SAGE Open Med. 2022 Feb 21;10:20503121221079488. doi: 10.1177/20503121221079488. eCollection 2022.
9
Venous Thromboembolism Risk and Adherence to Pharmacological Thromboprophylaxis in Hospitalized Patients in Uruguay: First Nationwide Study.乌拉圭住院患者静脉血栓栓塞风险与药物性血栓预防治疗的依从性:首个全国性研究。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241256368. doi: 10.1177/10760296241256368.
10
Prophylaxis of venous thromboembolism in hospitalized patients admitted from Spanish emergency departments: the PROTESU II study.住院患者预防静脉血栓栓塞:PROTESU II 研究。
Emergencias. 2024 Aug;36(4):271-280. doi: 10.55633/s3me/051.2024.

引用本文的文献

1
Caprini versus Padua venous thromboembolism risk assessment scores: A comparative study in hospitalized patients at a tertiary center.卡普里尼与帕多瓦静脉血栓栓塞风险评估评分:在一家三级中心住院患者中的比较研究。
Saudi Med J. 2024 Apr;45(4):362-368. doi: 10.15537/smj.2024.45.4.20230954.
2
Safety and effectiveness of thromboprophylaxis use in hospitalized elderly medical patients at a Saudi tertiary care center.沙特一家三级医疗中心住院老年内科患者使用血栓预防措施的安全性和有效性。
Saudi Pharm J. 2021 May;29(5):456-461. doi: 10.1016/j.jsps.2021.04.008. Epub 2021 Apr 28.

本文引用的文献

1
Deep vein thrombosis: pathogenesis, diagnosis, and medical management.深静脉血栓形成:发病机制、诊断及药物治疗
Cardiovasc Diagn Ther. 2017 Dec;7(Suppl 3):S276-S284. doi: 10.21037/cdt.2017.09.01.
2
Predictors and Outcomes of Recurrent Venous Thromboembolism in Elderly Patients.老年患者复发性静脉血栓栓塞的预测因素和结果。
Am J Med. 2018 Jun;131(6):703.e7-703.e16. doi: 10.1016/j.amjmed.2017.12.015. Epub 2018 Jan 4.
3
Thromboprophylaxis and mortality among patients who developed venous thromboembolism in seven major hospitals in Saudi Arabia.沙特阿拉伯七家主要医院中发生静脉血栓栓塞症患者的血栓预防与死亡率
Ann Thorac Med. 2017 Oct-Dec;12(4):282-289. doi: 10.4103/atm.ATM_101_17.
4
Venous thromboembolism risks and prophylaxis in King Fahad Hospital, Madinah, Saudi Arabia.沙特阿拉伯麦地那法赫德国王医院的静脉血栓栓塞风险与预防
J Epidemiol Glob Health. 2017 Dec;7(4):295-298. doi: 10.1016/j.jegh.2017.09.003. Epub 2017 Sep 22.
5
Venous thromboembolism in the elderly: A narrative review.老年人静脉血栓栓塞症:叙述性综述。
Thromb Res. 2017 Jul;155:140-147. doi: 10.1016/j.thromres.2017.05.015. Epub 2017 May 17.
6
The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs.美国新发静脉血栓栓塞症的经济负担:对估计的可归因医疗费用的综述。
Thromb Res. 2016 Jan;137:3-10. doi: 10.1016/j.thromres.2015.11.033. Epub 2015 Nov 24.
7
Lifetime Risk of Venous Thromboembolism in Two Cohort Studies.两项队列研究中静脉血栓栓塞的终生风险
Am J Med. 2016 Mar;129(3):339.e19-26. doi: 10.1016/j.amjmed.2015.10.014. Epub 2015 Nov 18.
8
Usage of venous thromboembolism prophylaxis at a tertiary care hospital in Aseer region of Saudi Arabia.沙特阿拉伯阿西尔地区一家三级医疗医院静脉血栓栓塞预防措施的使用情况。
Saudi Med J. 2015 Nov;36(11):1367-8. doi: 10.15537/smj.2015.11.12231.
9
The Saudi clinical practice guideline for the diagnosis of the first deep venous thrombosis of the lower extremity.沙特阿拉伯下肢深静脉血栓形成的诊断临床实践指南。
Ann Thorac Med. 2015 Jan-Mar;10(1):3-15. doi: 10.4103/1817-1737.146849.
10
Cost-effectiveness of prevention and treatment of VTE.静脉血栓栓塞症预防与治疗的成本效益
Clin Appl Thromb Hemost. 2013 Mar-Apr;19(2):220-3. doi: 10.1177/1076029612474840v.

沙特一家三级医疗中心老年内科患者的静脉血栓栓塞预防用药模式:成功还是失败?

Venous thromboembolism prophylaxis-prescribing patterns among elderly medical patients in a Saudi tertiary care center: success or failure?

作者信息

Alabdulkarim Dalal A, Almohammed Omar A, Al Ammari Maha A, Almaklafi Nada S, Alkathiri Munirah A, Aljohani Manal A

机构信息

Pharmaceutical Care Service, Ministry of the National Guard-Health Affairs, Riyadh, Saudi Arabia.

King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.

出版信息

J Geriatr Cardiol. 2020 Dec 28;17(12):775-781. doi: 10.11909/j.issn.1671-5411.2020.12.004.

DOI:10.11909/j.issn.1671-5411.2020.12.004
PMID:33424945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7762694/
Abstract

BACKGROUND

Hospitalized elderly patients are at high risk of venous thromboembolism (VTE), and the appropriate use of thromboprophylaxis can significantly reduce the incidence of VTE in high-risk patients. We investigated the pattern of VTE prophylaxis administration among elderly medical patients and assessed its appropriateness based on the American College of Chest Physicians (ACCP) recommendations.

METHODS

A cross-sectional single-center study was conducted between October 2019 and March 2020, including hospitalized (> 48 h), elderly (≥ 60 years), medical patients, and excluding patients receiving anticoagulant for other reason, having contraindication to thromboprophylaxis, or had VTE diagnosed within 48 h. The Padua prediction score was used to determine the patients' risk for VTE, and thromboprophylaxis use was assessed against the ACCP recommendations.

RESULTS

The study included 396 patients with an average age of 75.0 ± 9.01 years, and most patients (71.7%) were classified as high risk for VTE development (Padua score ≥ 4 points). Thromboprophylaxis use was inappropriate in 27.3% of patients, of whom 85.2% were ineligible but still received thromboprophylaxis. Patients who were classified as low risk of VTE were more likely to receive inappropriate thromboprophylaxis (AOR = 76.5, 95% CI: 16.1-363.2), whereas patients with acute infection or rheumatologic disorder were less likely to receive inappropriate thromboprophylaxis (AOR = 0.46, 95% CI: 0.22-0.96).

CONCLUSIONS

Although the use of thromboprophylaxis among high-risk elderly patients was reasonably adequate, a large proportion of low-risk patients were exposed to unnecessary risk through inappropriate overutilization of thromboprophylaxis. Thus, healthcare providers should accurately assess patients' risk before prescribing thromboprophylaxis to ensure patient safety.

摘要

背景

住院老年患者发生静脉血栓栓塞症(VTE)的风险很高,适当使用血栓预防措施可显著降低高危患者VTE的发生率。我们调查了老年内科患者VTE预防措施的使用模式,并根据美国胸科医师学会(ACCP)的建议评估其合理性。

方法

于2019年10月至2020年3月进行了一项横断面单中心研究,纳入住院(>48小时)、老年(≥60岁)内科患者,排除因其他原因接受抗凝治疗、有血栓预防禁忌证或在48小时内被诊断为VTE的患者。使用帕多瓦预测评分来确定患者发生VTE的风险,并根据ACCP的建议评估血栓预防措施的使用情况。

结果

该研究纳入了396例患者,平均年龄为75.0±9.01岁,大多数患者(71.7%)被归类为发生VTE的高危患者(帕多瓦评分≥4分)。27.3%的患者血栓预防措施使用不当,其中85.2%不符合条件但仍接受了血栓预防措施。被归类为VTE低风险的患者更有可能接受不适当的血栓预防措施(调整后比值比[AOR]=76.5,95%置信区间[CI]:16.1-363.2),而患有急性感染或风湿性疾病的患者接受不适当血栓预防措施的可能性较小(AOR=0.46,95%CI:0.22-0.96)。

结论

虽然高危老年患者血栓预防措施的使用基本合理,但很大一部分低风险患者因不适当的过度使用血栓预防措施而面临不必要的风险。因此,医疗保健提供者在开出血栓预防药物之前应准确评估患者的风险,以确保患者安全。